Page last updated: 2024-08-24

imiquimod and antimony

imiquimod has been researched along with antimony in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowlati, Y; Eskandari, SE; Firooz, A; Ghoorchi, MH; Gorouhi, F; Hooshmand, B; Khamesipour, A; Khatami, A; Nassiri-Kashani, M; Rashighi-Firoozabadi, M1
Minodier, P; Parola, P1
Calderon, W; Cruz, M; Gyorkos, TW; Llanos-Cuentas, A; Matlashewski, G; Miranda-Verastegui, C; Rahme, E; Tulliano, G; Ward, B1

Reviews

1 review(s) available for imiquimod and antimony

ArticleYear
Cutaneous leishmaniasis treatment.
    Travel medicine and infectious disease, 2007, Volume: 5, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine

2007

Trials

2 trial(s) available for imiquimod and antimony

ArticleYear
Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Archives of dermatology, 2006, Volume: 142, Issue:12

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Animals; Antimony; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Single-Blind Method; Treatment Outcome

2006
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
    PLoS neglected tropical diseases, 2009, Jul-28, Volume: 3, Issue:7

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunologic Factors; Leishmaniasis, Cutaneous; Male; Middle Aged; Peru; Toll-Like Receptor 7; Treatment Outcome; Young Adult

2009